Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × ponatinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Neoplasms 6 Leukemia 5 Neoplasms by Histologic Type 4 Myeloproliferative Disorders 4 Leukemia, Myeloid 4 Hematologic Diseases 4 Bone Marrow Diseases 4 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Myeloid, Chronic-Phase 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Piebaldism 1 Malignant Hepatobiliary Neoplasm 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Carcinoma, Squamous Cell 1 Blast Crisis 1 Adenocarcinoma of Lung 1

Interventions

pembrolizumab 14 Paclitaxel 14 Carboplatin 10 Bevacizumab 6 rucaparib 5 lenvatinib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Taxes 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ipilimumab 2 Gemcitabine 2 Fulvestrant 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡